GlassScriptPhysician profile
Michele Spooner
NPI 1699811877
$1,466.26
in general payments reported to CMS, 2019-2025
17 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $58.33 · 2021: $12.73 · 2022: $112 · 2023: $284 · 2024: $507 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $203.65 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $191.55 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $189.34 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $158.31 | 2019-2023 | Tecnis Iol, Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $151.27 | 2019-2023 | |
| Biotissue Holdings INC. | $106.31 | 2019-2023 | |
| Harrow Eye, LLC | $101.35 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $74.45 | 2019-2021 | |
| Rxsight INC | $71.31 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Aerie Pharmaceuticals, INC. | $39.93 | 2019-2020 | |
| Glaukos Corporation | $39.47 | 2024 | Radius |
| Ani Pharmaceuticals, INC. | $31.32 | 2024-2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $30.56 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $28.56 | 2023 | Tyrvaya |
| Alcon Vision LLC | $21.09 | 2025 | Tryptyr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $16.64 | 2023 | Tepezza |
| Eyepoint US, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Spooner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.